First report of an adult female patient with endobronchial inflammatory myofibroblastic tumor in Taiwan: A case report

Yan-Ting Lin; Shih-Hao Huang; Chih-Hao Chang; Ping-Chi Hsu; Chih-Wei Wang; Chung-Shu Lee

doi:10.1111/1759-7714.14104

First report of an adult female patient with endobronchial inflammatory myofibroblastic tumor in Taiwan: A case report

Thorac Cancer. 2021 Oct;12(20):2807-2810. doi: 10.1111/1759-7714.14104. Epub 2021 Sep 14.

Authors

Yan-Ting Lin¹, Shih-Hao Huang^{1

2

3}, Chih-Hao Chang^{1

2

3}, Ping-Chi Hsu^{1

2}, Chih-Wei Wang⁴, Chung-Shu Lee^{1

2

3}

Affiliations

¹ Department of Internal Medicine, Chang Gung Memorial Hospital, Chang Gung University, School of Medicine, Taipei, Taiwan.
² Department of Thoracic Medicine, Chang Gung Memorial Hospital, Chang Gung University, School of Medicine, Taipei, Taiwan.
³ Department of Pulmonary and Critical Care Medicine, New Taipei Municipal Tucheng Hospital, New Taipei City, Taiwan.
⁴ Department of Anatomic Pathology, Chang Gung Memorial Hospital, Taoyuan City, Taiwan.

Abstract

An inflammatory myofibroblastic tumor (IMT) of the respiratory system is an uncommon disease. In Taiwan, there is a lack of previous studies on tracheobronchial IMT. The tumor is characterized by overexpression of anaplastic lymphoma receptor tyrosine kinase (ALK)-1. Surgical resection is the standard treatment of choice nowadays.

Keywords: endobronchial tumor; inflammatory myofibroblastic tumor; lung collapse.

Publication types

Case Reports

MeSH terms

Anaplastic Lymphoma Kinase / metabolism
Bronchial Neoplasms / surgery*
Dyspnea
Female
Humans
Middle Aged
Neoplasms, Muscle Tissue / surgery*
Taiwan

Substances

Anaplastic Lymphoma Kinase